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1. Introduction 
Breast cancers, like other forms of cancer, possess the ability for uncontrolled proliferation 
while resisting cell death [1]. This undue proliferation is a consequence of apoptosis evasion 
as well as loss of normal cell cycle control. Apoptosis is an efficient and uniquely regulated 
mode of cell death, involving the interplay of many factors. In mammals, there are two major 
pathways of apoptosis viz., the death receptor mediated pathway (extrinsic pathway) and the 
mitochondrial mediated pathway (intrinsic pathway). Caspases are the key regulatory 
proteins for both pathways [2]. The extrinsic pathway requires the binding of ligands such as 
tumor necrosis factor α (TNFα), Fas ligand (Fas-L) and TNF-related apoptosis-inducing 
ligand (TRAIL) to the death receptor on cell surfaces and corresponding transduction of 
signals leading to apoptosis [3]. The intrinsic pathway, on the other hand, is mediated by the 
release of cytochrome c by the mitochondrial following DNA damage. The released 
cytochrome c then induces the formation of apoptosomes composed of apoptotic protease 
activating factor 1 (Apaf-1), procaspase 9, and either ATP or dATP [4]. Caspase 9 is a 
downstream factor that activates the executioner caspase-3, which cleaves substrates such as 
Poly (ADP-ribose) polymerase (PARP) [5]. The activated caspase 3 then initiates the caspase 
cascade that culminates in the demolition of the cell [6]. 
In this study, the colorimetric microculture tetrazolium assay [7] was employed to access the 
cells viability while assays including morphology studies, Annexin V-FITC Assay and DNA 
fragmentation were thereafter utilized to ascertain the mode of the cell death. 
2. Materials and methods 
The chemical and reagents used in the study were; MTT (3-[4, 5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) (PhytoTechnology Laboratories, USA), DMSO 
(dimethylsulfoxide) (Fisher Scientific, UK), Dulbecco’s Modified Eagle’s Medium (DMEM) 
and Roswell Park Memorial Institute medium (RPMI 1640) powders with L-glutamine 
(GIBCO, New Zealand), fetal bovine serum (FBS), horse serum, trypsin–EDTA, phosphate-
buffered saline (PBS) tablets and penicillin (10,000 U/mL)–streptomycin (10 mg/mL) 
(Sigma-Aldrich, USA), acridine orange (AO) and propidium iodide (PI), annexin V-FITC 
(BD Pharmingen), and gel red nucleic acid stain and apoptotic DNA ladder detection kit 
(Abcam, USA). 
2.1. Cell culture 
The cell culture procedures were carried out in an aseptic condition in a Class II biohazard 
cabinet according to good cell culture practice (GCCP) guidelines. The MCF-7 breast cancer 
cell line (ATCC, USA) were grown in 25 cm
2
 tissue culture flasks (TPP, Switzerland) and 
incubated in an incubator (Binder, Germany) at 37°C under a humidified atmosphere of 5% 
CO2. The cells were maintained in RPMI supplemented with 10% FBS and 1% penicillin–
streptomycin. Upon reaching about 80% confluency, the cells were washed twice with PBS 
and 1 mL of trypsin–EDTA solution was added to detach the monolayer cells. The trypsin 
was inactivated by the addition of the complete cell growth medium and the cells were 
collected by centrifugation at 1000 rpm (Hettich Universal 32 R centrifuge, DJB Labcare 
Ltd., UK) for 5 min before discarding the medium. The cell count was determined using a 
hemocytometer counting chamber (Marienfeld, Germany) and about 0.5 to 1 × 10
6
 cells were 
subcultured into a fresh 25 cm
2
 tissue culture flask containing 6 ml of fresh medium at the 
subcultivation ratio of 1:4. The cultures were incubated at 37°C under 5% CO2 and 95% air. 
2.2. Cryogenic preservation and recovery 
The cells were preserved in liquid nitrogen to avoid loss of their original characteristics. 
Briefly, the cells growing in the exponential phase were subcultured. Following detachment 
and centrifugation, the cells were resuspended in freezing medium containing 90% FBS and 
10% DMSO, as a cryoprotective agent, to yield a final cell density of 2 to 5 × 10
6
 cells/mL. 
Subsequently, 1 mL of cell suspension was transferred into each labeled cryotube and 
allowed to stand at −20°C for 2 hours and at −80°C overnight before storage in liquid 
nitrogen (−196°C) (CBS Cryosystem). When needed, the cells were recovered by thawing 
with gentle agitation in water bath at 37°C for approximately 2 min. The cell suspension was 
transferred into a sterile 15 mL centrifuge tube (TPP, Switzerland) containing prewarmed 
complete growth medium in a biosafety cabinet and centrifuged at 1000 rpm (Hettich 
Universal 32 R centrifuge, DJB Labcare Ltd., UK) for 5 min at room temperature to remove 
the cryoprotective agent (DMSO). Finally, the cell pellets were resuspended in culture media 
and transferred to a 25cm
2
 culture flask (TPP, Switzerland), incubated at 37°C in a CO2 
incubator. After 2 days, the medium was replaced with fresh complete growth medium. 
2.3. Plating 
At about 80% confluency, the cells were collected and the concentration was determined 
using a hemocytometer. Briefly, 0.5 × 10
5
 cells/mL were dispensed into each well of a 96-
well flat bottom tissue culture plate. To obtain the desired plating concentration of 0.5 × 10
5
 
cells/mL, the initial cell concentration was adjusted with culture medium using the following 
formula: 
M1V1=M2V2 
E1 
where M1 is the initial cell concentration, V1 is the initial cell suspension volume, M2 is the 
final cell concentration, and V2 is the final cell suspension volume. 
Using a multichannel pipette, 100 μL of the cell suspension was dispensed into each well, 
except the blank wells, which received 200 μL of culture medium. The cell-seeded plate was 
incubated overnight at 37°C to facilitate attachment. 
2.4. Preparation of the test agents 
Artonin E was kindly donated by Dr. Najihah Hashim of the Department of Pharmacy, 
Faculty of Medicine, University of Malaya. The compound was isolated from Artocarpus 
elasticus, characterized and identified as reported by [8]. The standard agents, Tamoxifen and 
Paclitaxel were purchase from Sigma Aldrich, St. Louis, MO, USA. These agents were 
dissolved in DMSO and normal saline respectively and then diluted with respective medium 
with highest final DMSO concentration of 0.1% for in vitro cell culture studies. They were 
diluted serially using culture medium to obtain concentrations in the range of 1.56–
100 μM. About 100 μL of each concentration of Artonin E, Tamoxifen and Paclitaxel 
solutions was added into appropriate wells in four replicates. 
2.5. Microculture tetrazolium assay 
The colorimetric microculture tetrazolium assay ([7] was used to assess breast cancer cell 
viability. The tetrazolium dye is converted into an insoluble formazan by the action of 
nicotinamide adenine dinucleotide hydrogenase present in metabolically active cells. This 
cellular conversion into a purple-colored formazan is directly proportional to the number of 
viable cells. Briefly, exponentially growing cells were seeded into a 96-well flat bottom 
tissue culture plate at a density of approximately 0.5 × 10
4
 cells/well and allowed to adhere to 
the plate by incubating at 37°C under 5% CO2 and 95% air overnight. Following cell 
attachment, the cells were incubated with the tested compounds at concentrations ranging 
from 1.56 to 100 μM. Control cells were treated with 0.01% of DMSO, which was equivalent 
to the amount of DMSO used as vehicle. After each of the 24, 48 and 72 h treatment time 
period, 20 μL of 5 mg/mL of MTT solution was added to each well and the plate was 
reincubated for 4 h to facilitate catalysis by mitochondrial dehydrogenases. Next, 100 μL 
DMSO was added to each well to solubilize the formazan crystals. The absorbances of the 
resultant solutions were determined colorimetrically at 570 nm. The experiment was 
performed in triplicate. 
We conducted a nonlinear regression analysis and utilized the GraphPad Prism software to fit 
a dose-response curve. The concentration of the compound that triggered a 50% growth 
inhibition was indicated at different time interval in Figure 1. The percentage viability used in 
fitting the dose-response curve was calculated using the following formula: 
%of cell viability=ATAC×100 
E2 
 
Figure 1. 
Viability of MCF-7 cell line treated with Artonin E. The half maximum growth inhibitory 
concentrations (IC50) were: 6.90, 5.10 and 3.77 μM Artonin E at 24, 48 and 72 h, 
respectively. 
Where the absorbance reading of treated samples is indicated as AT while the absorbance of 
control samples treated with 0.01% of DMSO equivalent to the concentration used in 
dissolving the tested agent is depicted as AC. 
2.6. Cell morphological study 
Acridine Orange (AO) and propidium iodide (PI) double staining assay was employed to 
determine the effect of Artonin E in the induction of breast cancer cell death. A total of 
3 × 10
5
 MCF-7 breast cancer cells were seeded in a six-well plate and exposed to various 
treatment concentrations of Artonin E (1.56–100 μM) at varying time points (24–72 h). The 
adherent MCF-7 cells were trypsinized, and centrifuged at 2000 rpm (Hettich Universal 32 R 
centrifuge, DJB Labcare Ltd., UK) for 5 min. The pellet was washed with ice-cold PBS, re-
centrifuged before suspending in 20 μL of PBS. The cells were thereafter stained on ice with 
20 μL dye containing 10 μg/mL of AO with 10 μg/mL of PI. Carl Zeiss Axioskop plus-2 
fluorescence microscope was used to visualize aliquots of 20 μL of the cell suspension. Three 
fields each containing at least 200 cells were immediately assessed for viability, early and 
late apoptosis as well as necrosis [9]. The experiment was performed in triplicate. 
2.7. Annexin V-FITC assay 
Apoptosis was also investigated by detection of externalized phosphatidylserine using the 
Annexin V Kit (BD Pharmingen, USA). The cell preparation was carried out in accordance 
with the manufacturer’s protocol. The prepared cells were finally subjected to flow 
cytometric analysis using laser emitting excitation light at 488 nm and a BD flow cytometer 
equipped with an Argon laser (Cyan ADP, DAKO, Glostrup, Denmark). The data were 
analyzed using the Summit V4.3 software. 
2.8. DNA fragmentation analysis 
Qualitative DNA fragmentation (Roche) kit was used in this analysis. Briefly, after 
trypsinization, 1 × 10
6
 cells were collected and washed twice with PBS. The cells were then 
pelleted by centrifugation at 3000 rpm for 5 min, the supernatant removed and replaced with 
200 μL of fresh PBS. The sample was thereafter lysed with 200 μL binding/lysis buffer 
consisting of 6 M guanidine-HCl, 10 mM urea, 10 mM Tris–HCl, 20% Triton X-100 (v/v), 
pH 4.4 and incubated for 10 min at 15–25°C. After the incubation, 100 μL of isopropanol 
was added and the mixture was filtered through a high pure spin filter tube combined with a 
clean collection tube and centrifuged at 8000 rpm for 1 min. The flow-through was discarded 
and the filter tube was combined again with the collection tube before washing with 500 μL 
of washing buffer consisting of 20 mM NaCl, 2 mM Tris–HCl, pH 7.5 in 20 mL with the 
addition of 80 mL ethanol. This washing step was done twice before spinning the tube dry at 
13,000 rpm (Eppendorf 5424 microcentrifuge, USA) for 10 s to remove any residual washing 
buffer. 
The extracted DNA was eluted into a fresh collection tube with 200 μL of prewarmed (70°C) 
elution buffer (10 mM Tris) and recentrifuged at 8000 rpm for 1 min. The quality of the 
extracted DNA was assessed with a nanodrop spectrophotometer (nanodrop lite 
spectrophotometer, Thermo Scientific, USA). The DNA sample was mixed with 1× loading 
dye and electrophoresed on 1% agarose gel 75 V for 1 h and stained with GelRed™ nucleic 
acid gel stain. The fragmented DNA was visualized under UV transilluminator and 
photographed with a chemiluminescence image analyzer system (Chemi-Smart, Vilber 
Lourmat, Germany). 
2.9. Statistical analysis 
All data collected were analyzed using the GraphPad Prism 5.0 (GraphPad Software Inc., La 
Jolla, CA, USA). One way analyses of variance was performed, followed by Turkey’s post 
hoc tests to compare replicate means of treatment and control groups. The significance was 
set at p < 0.05. 
3. Results 
3.1. Growth inhibitory effect of Artonin E on MCF-7 breast cancer cells 
Artonin E, at concentrations of 6.9, 5.10 and 3.77 μM induced a half maximal growth 
inhibitory effect on estrogen receptor-positive breast cancer cells (Figure 1) at 24, 48 and 
72 h respectively. 
3.2. Artonin E treated MCF-7 breast cancer cells displayed morphology of 
apoptosis 
The results of the AO and PI double staining analysis showed that Artonin E treated breast 
cancer cells displayed morphological features typical of apoptosis. These features included 
chromatin condensation and membrane blebbing. The control breast cancer cells which were 
not exposed to Artonin E had their normal nuclear structure displayed as green fluorescence. 
Early apoptotic cells were observed as bright green fluorescence resulting from the 
interposition of acridine orange with the fragmented DNA whereas late stage apoptosis 
(Figure 2C and D) was observed as reddish-orange, resulting from the binding of propidium 
iodine to denatured DNA. The apoptosis inducing effect of Artonin E was observed to be 
time and concentration dependent. 
 
Figure 2. 
Acridine orange/propidium iodide double staining of MCF-7 cells after 24 h exposure. (A) 
Control, (B) 3, (C) 10, (D) 30 μM Artonin E. VC = viable cells; BL = cell membrane 
blebbing; CC = chromatin condensation; EA = early apoptosis; LA = late apoptosis; MN 
arginated nuclear chromatin; SN secondary necrosis. Magnification: 200×. 
Challenging the cancer cells with Artonin E caused a significant (p < 0.05) loss in the 
proportion of viable MCF-7 breast cancer cells (Figure 3) from 94.5% to 67, 38, and 21.5% 
after treatment with 3, 10, and 30 μM Artonin E respectively. There was no significant 
(p ≥ 0.05) increase in necrotic breast cancer cells except after exposure to 30 μM of Artonin 
E. This percentage decreased. There was a concentration and time dependent significant 
(p < 0.05) increase in the proportion of cells that entered the apoptotic phase. 
 
Figure 3. 
Quantification of early and late apoptotic MCF-7 cells after AO/PI double staining analysis. 
All values are mean ± standard deviation. *at each time point, means significantly different 
for control at p < 0.05. 
3.3. Annexin V-FITC assay flowcytometric analysis 
The externalized phosphatidyl serine was detected with Annexin V-FITC dye as an indication 
of apoptosis induced upon treatment of breast cancer cells with Artonin E. From the results, 
there was a significant (p < 0.05) shift in the population of the breast cancer cells from 
viability to late apoptosis (Figure 4). This effect was concentration as well as time dependent. 
After 24 h exposure of the cancer cells to Artonin E, the percentage viability decreased from 
97.78% to 81.27, 36.33 and 12.0 6% when treated with 3, 10 and 30 μM of Artonin E 
respectively. 
 
Figure 4. 
Representative histogram analysis of the Annexin V assay in MCF-7 cells treatment with 
Artonin E at 24 and 48 h. Viable cells population are shown in the lower left quadrant, while 
those undergoing early apoptosis are in the lower right quadrant. The upper right quadrant 
shows cells at late stage of apoptosis, and in upper left corner, cells at the necrotic stage are 
shown. 
3.4. DNA fragmentation analysis 
Another unique feature of apoptosis is DNA fragmentation which can be visualized by 
agarose gel electrophoresis [10]. From the results, nuclear DNA fragmentation occurred after 
treatment with Artonin E. This was observed in the breast cancer cells (Figure 5) in 
comparison to the untreated control group which showed intact DNA. 
 
Figure 5. 
DNA fragmentation in MCF-7 cells treated with Artonin E after 24 h. The positive control 
cells were treated with 4 μg/mL camptothecin, the DNA marker is a 1 kb ladder. 
4. Discussion 
The death of cancer cells in a tumor is the ultimate goal of cancer drug discovery. Unlike 
normal cells, cancer cells possess the ability to proliferate uncontrollably while evading 
apoptosis. Apoptosis induction is thus a valuable characteristic of a potential anticancer drug. 
Hence, the cytotoxic effect of a compound can be accessed by investigating its growth 
inhibition on the target cancer cells. It is also vital to examine the mode of cell death induced 
by the compound. In this study, Artonin E, previously shown to be drug-like with a better in 
silico growth inhibitory properties when compared with similar structural analogues [11], was 
evaluated for its in vitro growth inhibition and mode of cell death induced in MCF-7 breast 
cancer cell line. 
Artonin E was found to significantly inhibit the proliferation of this breast cancer cells in a 
dose and time dependent manner. At 24, 48 and 72 h, Artonin E showed half maximal 
inhibitory concentrations of 6.90, 5.10 and 3.77 μM, respectively. MCF-7 is estrogen receptor 
positive, progesterone positive and HER2 (human epidermal growth factor 2) positive and 
has wild type p53 [12]. Etti et al. [11] reported the in silico affinity of Artonin E to the human 
estrogen receptor α and pin pointed Artonin E as having greater binding affinity for the 
estrogen receptor α among the reported structural analogues from the Artocarpus. It was also 
reported that the prenylation together with the 4
1
, 5
1
 vicinal diol groups in Artonin E had 
enhanced its affinity to the human estrogen receptor α. This affinity of Artonin E to the 
human estrogen receptor can be said to be mostly responsible for its better growth inhibition 
in MCF-7 cells observed in this study. Consistent with our findings, Obiorah et al. [13] 
discovered that ERα was exclusively responsible for the apoptosis induction of genistein, 
equol, and coumestrol, compounds which are structurally similar to Artonin E. They 
confirmed the phenomenon by a gene knockdown of ERα which prevented growth inhibition 
and apoptosis induced by these phytoestrogens. These support the involvement of the 
estrogen receptor in the growth inhibitory potential of Artonin E. Similarly, Turner et al. [14] 
also reported that prenylflavones show selectivity to estrogen receptors. Thus, it is of no 
doubt, that the affinity of Artonin E for the estrogen receptor is a possible basis for the 
observed sensitivity of MCF-7 breast cancer cells to the compound. 
Various modes of cell death include apoptosis, necrosis and autophagy. However, from the 
results of this study, Artonin E provoked morphological features typical of apoptosis in the 
Artonin E treated breast cancer cells. In support of this, Carou et al. [15] and Gerl and Vaux 
[16], reported that apoptosis results in unique morphological changes including cell 
shrinkage, membrane alteration, DNA fragmentation and nuclear condensation. These 
features were observed in this study after treating the breast cancer cells with Artonin 
E. Succinctly, agents that trigger apoptosis are very essential in the management of cancer, 
giving that a unique hallmark of cancer cells is apoptosis evasion which is also implicated in 
its pathogenesis [17]. Hence, induction of apoptosis becomes a strategy for cancer drug 
discovery [18]. 
A compromise in the phospholipid membrane asymmetry of a cell, results in the 
externalization of phosphatidylserine. To further strengthen the assessment of the apoptotic 
mode of cell death, annexin V FITC in combination with a DNA binding fluorochrome, PI 
were utilized [9, 19, 20]. In this study, Artonin E has been seen to significantly reduce the 
population of viable breast cancer cells in a concentration and time dependent manner while 
increasing the population undergoing apoptosis. Thus, treatment of breast cancer cells with 
Artonin E distorted the integrity of the lipid bilayer of the cancer cells, exposing their 
phospholipid as detected in this study. These observations qualifies apoptosis as the mode of 
cell death induced by Artonin E. 
Apoptotic endonucleases in the course of apoptosis, degrades chromosomal DNA into 
fragments [21]. This fragmented DNA can be visualized in a gel electrophoresis. In this 
study, after treating the cancer cells with Artonin E, its DNA was seen to have degraded into 
fragments in comparison to the untreated control. This DNA fragment induction by Artonin 
E, confirms apoptosis as the mode of cell death [22] which was also seen in the morphology 
of Artonin E treated breast cancer cells and the Annexin V-FITC flowcytometric assays. 
5. Conclusion 
Artonin E inhibited the unregulated growth of breast cancer cells and induced apoptosis in the 
cancer cells. It produced enhanced cytotoxicity on the estrogen receptor positive MCF-7 cells 
thus, halting its progression to immortality. 
 
